UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:February 24,
BioLineRx (NASDAQ:BLRX)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse BioLineRx
BioLineRx (NASDAQ:BLRX)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse BioLineRx

Actualités Biolinerx Ltd.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Vendredi 24 Mai 2024 ( il y a 2 jours) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Vendredi 17 Mai 2024 ( il y a 1 semaine) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lundi 6 Mai 2024 ( il y a 3 semaines) • Edgar (US Regulatory)
BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting
Mercredi 17 Avril 2024 ( il y a 1 mois) • PR Newswire (US)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lundi 4 Mars 2024 ( il y a 3 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mercredi 28 Février 2024 ( il y a 3 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Vendredi 16 Février 2024 ( il y a 3 mois) • Edgar (US Regulatory)
Form EFFECT - Notice of Effectiveness
Lundi 8 Janvier 2024 ( il y a 5 mois) • Edgar (US Regulatory)
Form S-8 - Securities to be offered to employees in employee benefit plans
Vendredi 29 Décembre 2023 ( il y a 5 mois) • Edgar (US Regulatory)
Form F-3 - Registration statement by foreign private issuers
Vendredi 29 Décembre 2023 ( il y a 5 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Jeudi 21 Décembre 2023 ( il y a 5 mois) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mardi 12 Décembre 2023 ( il y a 5 mois) • Edgar (US Regulatory)

Plus d'articles sur Biolinerx Ltd.